Virtual 2020

Browse:
Pre-Congress Content
Sunday, 06.09.2020
Monday, 07.09.2020
Tuesday, 08.09.2020
Wednesday, 09.09.2020

 

View the presentations you missed during Congress!

More than 1,100 webcasts and slide presentations, 3,500 e-posters and 4,000 abstracts from the Virtual Congress 2020 and are now available.

Citations should be made in the following way: Authors. Title. Eur Respir J 2020; 55: Suppl. 65, abstract number.


Real life in the field of idiopathic pulmonary fibrosis: treatments and registries

E-poster session
Chairs: C. Ravaglia (Forlì, Italy), Y. Kondoh (Seto (Aichi), Japan)
Characteristics and clinical management of IPF patients in Spain: prospective, observational, multicentric study (OASIS study).
A. Romero Ortiz (Granada, Spain), M. Rodríguez-Nieto (Madrid, Spain), A. Villar (Barcelona, Spain), E. Cano-Jiménez (Lugo, Spain), A. Ramón (Barcelona, Spain), S. Armengol (Barcelona, Spain), E. Alhaja (Barcelona, Spain), M. Artés (Barcelona, Spain)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Cluster analysis and survival in patients with Idiopathic pulmonary fibrosis
D. Kalafatis (Stockholm, Sweden), L. Carlson (Stockholm, Sweden), J. Gao (Stockholm, Sweden), C. Li (Stockholm, Sweden), I. Pesonen (Stockholm, Sweden), C. Sköld (Stockholm, Sweden)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Acute Exacerbation of IPF - Experience of a Portuguese RICU
J. Rodrigues Barbosa (Lisboa, Portugal), S. Salgado (Lisboa, Portugal), P. Esteves (Lisboa, Portugal), C. Bárbara (Lisboa, Portugal)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Russian IPF Registry: time of inclusion impacts patients’ status
S. Chikina (Moscow, Russian Federation), S. Avdeev (Moscow, Russian Federation), I. Tyurin (Moscow, Russian Federation), A. Cherniak (Moscow, Russian Federation), Z. Merzhoeva (Moscow, Russian Federation)
Congress or journal article abstract
Congress or journal article abstract
Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis (IPF): analysis from the Swedish IPF registry
J. Gao (Stockholm, Sweden), D. Kalafatis (Stockholm, Sweden), L. Carlson (Stockholm, Sweden), C. Li (Stockholm, Sweden), I. Pesonen (Stockholm, Sweden), M. Sköld (Stockholm, Sweden)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Prevalence of idiopathic pulmonary fibrosis in Japan and the US: a claims-based retrospective study
Y. Kondoh (Aichi, Japan), T. Suda (Shizuoka, Japan), Y. Hongo (Tokyo, Japan), M. Yoshida (Tokyo, Japan), S. Hiroi (Tokyo, Japan), K. Iwasaki (Tokyo, Japan), T. Takeshima (Tokyo, Japan), S. Homma (Tokyo, Japan)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Long-term outcomes of antifibrotic treatments in patients with idiopathic pulmonary fibrosis: Real-world experience
S. Nayci (Mersin, Turkey), D. Polat (Mersin, Turkey), E. Ozgur (Mersin, Turkey), C. Özge (Mersin, Turkey)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Factors influencing best tolerated dose of pirfenidone (PFD) in patients with IPF
N. Agrawal (Mumbai, India), P. Vaidya (Mumbai, India), R. Shah (Mumbai, India), V. Chavhan (Mumbai, India), J. Leuppi (Liestal, Switzerland), A. Leuppi-Taegetmeyer (Liestal, Switzerland), P. Chhajed (Mumbai, India)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Safety and Tolerability of Combination Therapy with Nintedanib and Pirfenidone for Idiopathic Pulmonary Fibrosis: A Multicenter, Retrospective, Observational Study in Japan
S. Hisata (Tochigi, Japan), M. Bando (Tochigi, Japan), S. Homma (Tokyo, Japan), K. Kataoka (Aichi, Japan), T. Ogura (Kanagawa, Japan), S. Izumi (Tokyo, Japan), S. Sakamoto (Tokyo, Japan), Y. Saito (Tokyo, Japan), K. Watanabe (Kyoto, Japan), Y. Shimizu (Tochigi, Japan), M. Kato (Tokyo, Japan), N. Inase (Tokyo, Japan)
Congress or journal article abstract
Congress or journal article abstract
Efficacy of low dose pirfenidone in idiopathic pulmonary fibrosis: Real world experiencefrom a tertiary university hospital
S. Kim (Seoul, Republic of Korea), J. Shin (Seoul, Republic of Korea), M. Song (Seoul, Republic of Korea), M. Park (Seoul, Republic of Korea), Y. Kang (Seoul, Republic of Korea)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Assessing the effectiveness of pirfenidone in changing the natural course of idiopathic pulmonary fibrosis: the data from European IPF Registry (eurIPFreg).
E. Krauss (Giessen, Germany), S. Tello (Giessen, Germany), R. Dartsch (Giessen, Germany), M. Korfei (Giessen, Germany), P. Mahavadi (Giessen, Germany), M. Stoehr (Giessen, Germany), J. Wilhelm (Giessen, Germany), R. Majeed (Giessen, Germany), P. Bonniaud (Dijon, France), C. Vancheri (Catania, Italy), A. Wells (London, United Kingdom), W. Seeger (Giessen, Germany), B. Crestani (Paris, France), A. Guenther (Giessen, Germany)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Impact of tidal volume, GAP index and anti-fibrotic treatment on disease progression and mortality in IPF patients
E. Krauss (Giessen, Germany), B. Ait Ilalne (Paris, France), C. Knittel (Giessen, Germany), J. Wilhelm (Giessen, Germany), R. Dartsch (Giessen, Germany), S. Tello (Giessen, Germany), P. Mahavadi (Giessen, Germany), M. Korfei (Giessen, Germany), W. Seeger (Giessen, Germany), B. Crestani (Paris, France), A. Guenther (Giessen, Germany)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
Y. Qiu (Princeton, NJ, United States of America), R. Zhao (Princeton, NJ, United States of America), B. Elpers (Princeton, NJ, United States of America), Y. Wang (Ann Arbor, MI, United States of America), L. Xie (Ann Arbor, MI, United States of America), J. Tang (Ann Arbor, MI, United States of America), A. Fischer (Princeton, NJ, United States of America)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Antithrombotics in idiopathic pulmonary fibrosis patients with concomitant antifibrotic therapy: a single centre real world experience
A. Stanziola (Napoli (NA), Italy), D. Pentangelo (Napoli (NA), Italy), R. D'Angelo (Napoli (NA), Italy), L. Capitelli (Napoli (NA), Italy), R. Rega (Napoli (NA), Italy), M. Bocchino (Napoli (NA), Italy), U. Malapelle (Napoli (NA), Italy)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Characteristics and management of patients with idiopathic pulmonary fibrosis treated with pirfenidone capsule or tablet formulation
V. Cottin (Lyon, France), S. Guéguen (Paris, France), S. Jouneau (Rennes, France), H. Nunes (Avicenne, France), B. Crestani (Paris, France), P. Bonniaud (Dijon, France), L. Wemeau (Lilles, France), D. Israel-Biet (Paris, France), M. Chevereau (Paris, France), I. Dufaure-Garé (Paris, France), S. Amselem (Paris, France), A. Clément (Paris, France)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Association between antifibrotic medications and pneumothorax or pneumomediastinum in patients with idiopathic pulmonary fibrosis
T. Akamatsu (Shizuoka, Japan), H. Nakayasu (Shizuoka, Japan), K. Tamura (Shizuoka, Japan), T. Masuda (Shizuoka, Japan), S. Takahashi (Shizuoka, Japan), Y. Tanaka (Shizuoka, Japan), H. Watanabe (Shizuoka, Japan), Y. Kishimoto (Shizuoka, Japan), K. Oishi (Shizuoka, Japan), M. Saigusa (Shizuoka, Japan), A. Yamamoto (Shizuoka, Japan), S. Morita (Shizuoka, Japan), K. Asada (Shizuoka, Japan), T. Shirai (Shizuoka, Japan)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Nintedanib in IPF: post hoc analysis of the Italian FIBRONET observational study
V. Poletti (Forlì, Italy), C. Albera (Turin, Italy), S. Harari (Milan, Italy), A. Pesci (Monza, Italy), A. Ori (Modena, Italy), G. Crespi (Milan, Italy), B. Campolo (Milan, Italy), C. Vancheri (Catania, Italy)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Results of antifibrotic drugs in the treatment of idiopathic pulmonary fibrosis. A real life study.
J. Hernandez Borge (Badajoz, Spain), A. Castañar Jover (Badajoz, Spain), L. Sierra Murillo (Badajoz, Spain), P. Iñigo Naranjo (Badajoz, Spain), S. Hernández Gómez (Badajoz, Spain), A. Sanz Cabrera (Badajoz, Spain)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
GAP scoring system in IPF patients treated with antifibrotics: prognostic performance and 1- to 3- years mortality: a retrospective study
L. De Sadeleer (Leuven, Belgium), T. Goos (Leuven, Belgium), J. Yserbyt (Leuven, Belgium), S. Verleden (Leuven, Belgium), W. Wuyts (Leuven, Belgium)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Characterize Idiopathic Pulmonary Fibrosis using Respiratory Oscillometry
J. Wu (Toronto, Canada), A. Vasileva (Toronto, Canada), E. Chang (Toronto, Canada), J. Ma (Toronto, Canada), Q. Huang (Toronto, Canada), A. Cassano (Toronto, Canada), M. Binnie (Toronto, Canada), S. Shapera (Toronto, Canada), J. Fisher (Toronto, Canada), C. Ryan (Toronto, Canada), C. Chow (Toronto, Canada)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster